Researchers at the University of California San Diego have identified a genetic link between liver enzymes and cocaine addiction, suggesting that drug metabolism plays a critical role in compulsive behavior. By studying more than 800 genetically diverse rats, the team found that specific variations in carboxylesterase genes—which break down cocaine in the liver—directly influence how the drug affects an individual, offering a potential new pathway for pharmacological treatments.
How does the liver influence cocaine addiction?
Addiction is traditionally viewed as a disorder rooted entirely in brain chemistry, but new research indicates the body’s metabolic processes are equally vital. According to the study published in Nature Communications, scientists identified a genetic “hotspot” on chromosome 19 that regulates how frequently subjects self-administer cocaine. This region contains the Ces1c and Ces1d genes, which produce enzymes responsible for breaking down the drug. Olivier George, PhD, a professor of psychiatry at UC San Diego School of Medicine, described this discovery as an “aha” moment, noting that addiction involves the entire body rather than just the brain.
The study suggests that addiction is not merely a “failure of will” but has a distinct biological basis. By mapping these genetic markers, researchers hope to move toward precision medicine, where treatments are tailored to an individual’s specific genetic profile.
What are the shared genetic markers of substance use?
The research team identified six genetic regions tied to addictive behaviors, several of which overlap with other substance use disorders. Beyond the liver-related genes, the study highlighted Trak2, which has been linked to cocaine use in humans, as well as Slc10a7, Plcl1, and Satb2. According to the data, these latter three genes have previously been associated with alcohol and tobacco use. This shared genetic architecture suggests that certain biological vulnerabilities may predispose individuals to multiple forms of chemical dependency.
How will this change future addiction treatment?
Current treatment models primarily focus on neurological interventions, but these findings point toward metabolic targets. By identifying carboxylesterase enzymes as “druggable” clinical targets, researchers believe it may be possible to develop medications that modify how the body processes cocaine, thereby reducing its addictive potential. The next phase of research, according to the study authors, involves determining exactly how these genetic variants alter enzyme function to drive compulsive drug-seeking behaviors.
Comparison: Animal Models vs. Human GWAS
The study, which represents the largest genetic experiment of cocaine self-administration in rats to date, shows high concordance with human genome-wide association study (GWAS) results. While human studies often struggle with environmental variables, the use of over 800 N/NIH Heterogeneous Stock rats allowed researchers to isolate specific genetic influences, which ranged from 7% to 16% heritability across measured traits.
When evaluating addiction research, look for studies that cross-reference animal models with human GWAS data. This “triangulation” increases the likelihood that findings will translate into effective clinical applications for humans.
Frequently Asked Questions
Is cocaine addiction purely genetic?
No. While the study confirms a significant biological and genetic basis for addiction, it does not suggest that genetics are the sole cause. These factors work in tandem with environmental and behavioral influences.
Can liver enzymes really treat drug addiction?
The researchers believe that targeting these enzymes could modify the physiological effects of cocaine, potentially making it easier for individuals to reduce or cease use by altering how the drug is metabolized.
What are the next steps for this research?
The research team is now focused on understanding the precise mechanisms by which specific genetic variants change enzyme function, which is a necessary step before human clinical trials can be considered.
Have questions about how genetics influence health? Subscribe to our newsletter for the latest updates on medical research and precision medicine, or explore our archives for more on the neuroscience of addiction.
